Table of Contents Introduction to GLP-1 Agonists What are GLP-1 Agonists? Glucagon-Like Peptide-1 (GLP-1) agonists are a groundbreaking class of medications that have transformed the treatment landscape for type 2 diabetes and obesity. These medications mimic the action of the GLP-1 hormone, which is naturally produced in the intestines. GLP-1 plays a crucial role in …
Table of Contents Introduction GLP-1 agonists have emerged as pivotal players in diabetes management, offering distinct mechanisms and notable benefits. Understanding their significance requires exploring their definition, action, and critical role in treating type 2 diabetes mellitus (T2DM). GLP-1 (Glucagon-like peptide-1) agonists, also called incretin mimetics, mimic the incretin hormones that regulate glucose metabolism. These …
Table of Contents Introduction In managing type 2 diabetes, Ozempic (semaglutide) stands out as a game-changer. As a glucagon-like peptide-1 receptor agonist (GLP-1 RA), Ozempic mimics the natural hormone GLP-1, crucial for regulating blood sugar by boosting insulin secretion, suppressing glucagon release, and inducing satiety. Type 2 diabetes, marked by insulin resistance and elevated blood …